Berkeley, CA, United States of America

Wei Yu

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Corporation, Tokyo Medical and Dental University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Yu. Retrieved from https://idiyas.com/inventor/wei-yu-gsmmx3u7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei Yu - Innovator in Cancer Detection

Introduction

Wei Yu is a notable inventor based in Berkeley, California. He has made significant contributions to the field of cancer detection through his innovative methods. His work focuses on identifying genes that exhibit characteristic behavior in various types of cancer, particularly anaplastic thyroid cancer.

Latest Patents

Wei Yu holds a patent for a method for detecting cancer and a method for suppressing cancer. The objective of this invention is to provide a reliable method for detecting cancer by identifying the amplification of a gene located in the p12 region of chromosome 8. This method serves as an indicator for canceration in specimens, offering a potential breakthrough in early cancer detection.

Career Highlights

Throughout his career, Wei Yu has worked with prominent organizations such as Fujifilm Corporation and Tokyo Medical and Dental University. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer detection.

Collaborations

Wei Yu has collaborated with esteemed colleagues, including Johji Inazawa and Issei Imoto. Their combined expertise has contributed to advancements in cancer research and detection methodologies.

Conclusion

Wei Yu's contributions to cancer detection through his patented methods highlight his role as an innovator in the medical field. His work continues to pave the way for advancements in early cancer diagnosis and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…